|
|
 |
| |
|
Home > Drug Companies > Monarch Pharmaceuticals
| |
Pharmaceutical Courses |
|
Pharmacy Technician
Allied College
Arnold, MO |
Pharmacy Technician
Allied College
Saint Ann, MO |
Pharmacy Technician
Cambridge College
Portland, OR |
Pharmacy Technician
Cambridge College
Seattle, WA |
Pharmacy Technician
High Tech Institute
Irving, TX |
Pharmacy Technician
High Tech Institute
Atlanta, GA |
Pharmacy Technician
High Tech Institute
Memphis, TN |
Pharmacy Technician
High Tech Institute
Minneapolis, MN |
Pharmacy Technician
High Tech Institute
Orlando, FL |
Pharmacy Technician
High Tech Institute
Sacramento, CA |
Pharmacy Technician
The Bryman School
Phoenix, AZ |
|
Monarch Pharmaceuticals
Monarch Pharmaceuticals an S and P 500 Index company is a vertically integrated branded pharmaceutical company that develops, manufactures, markets, and sells therapies and technologies primarily in cardiovascular metabolics, neuroscience, and hospital acute care.
Monarch Pharmaceuticals has a well recognized and highly prescribed portfolio of core marketed products in its three therapeutic areas, plus other products. In addition, King has a robust R and D pipeline including three products in Phase III and two products in Phase II of clinical development. The Company has unique strengths in commercialization, advanced clinical development, manufacturing, and regulatory affairs, which make the company a proven partner of choice for late stage compounds and novel branded prescription pharmaceutical products and technologies.
Their business model offers the best of a big and small company in one fully integrated pharmaceutical company. It is an agile corporation whose size enables it to build close, personal one on one relationship with business development partners and move quickly to capitalize on scientific advances that address patient needs.
Monarch also has the breadth and depth of resources that enable it too efficiently and cost effectively bring clinically innovative pharmaceuticals and technologies to market. These include a unique, large scale commercial footprint in the United States, a highly cost effective, readily scalable R and D function, an efficient supply chain, robust manufacturing capability, and long time expertise in regulatory affairs.
Monarch will continue to acquire new products for commercialization. Several promising, novel candidates have been identified and the company is progressing toward such acquisitions. The objective of the company is to develop late stage, patented drugs intended for specialty or niche markets. The intent is to self fund the development of these products from revenues generated by product sales.
The Company’s vision is to lead the way to a healthier world. By carrying out this vision at every level of their organization, they will be recognized by their employees, customers and shareholders as the best pharmaceutical company in the world, resulting in value.
Back to Drug Companies
|
|
|
|
|
|
|
|